Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Open Access
- 15 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (8), 2545-2553
- https://doi.org/10.1182/blood-2005-08-024976
Abstract
Retroviral vectors with long terminal repeats (LTRs), which contain strong enhancer/promoter sequences at both ends of their genome, are widely used for stable gene transfer into hematopoietic cells. However, recent clinical data and mouse models point to insertional activation of cellular proto-oncogenes as a dose-limiting side effect of retroviral gene delivery that potentially induces leukemia. Self-inactivating (SIN) retroviral vectors do not contain the terminal repetition of the enhancer/promoter, theoretically attenuating the interaction with neighboring cellular genes. With a new assay based on in vitro expansion of primary murine hematopoietic cells and selection in limiting dilution, we showed that SIN vectors using a strong internal retroviral enhancer/promoter may also transform cells by insertional mutagenesis. Most transformed clones, including those obtained after dose escalation of SIN vectors, showed insertions upstream of the third exon of Evi1 and in reverse orientation to its transcriptional orientation. Normalizing for the vector copy number, we found the transforming capacity of SIN vectors to be significantly reduced when compared with corresponding LTR vectors. Additional modifications of SIN vectors may further increase safety. Improved cell-culture assays will likely play an important role in the evaluation of insertional mutagenesis.Keywords
This publication has 33 references indexed in Scilit:
- Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisBlood, 2005
- Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor CellsPLoS Biology, 2004
- Protection and selection for gene therapy in the hematopoietic systemThe Journal of Gene Medicine, 2004
- Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived PeptidesJournal of Virology, 2004
- RTCGD: retroviral tagged cancer gene databaseNucleic Acids Research, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiationBlood, 2003
- Retroviral insertional mutagenesis: Tagging cancer pathwaysPublished by Elsevier BV ,2003
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000